REBACIN® inhibits E6/E7 oncogenes in clearance of human papillomavirus infection
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.1047222
Abstract: Previous studies have demonstrated that REBACIN® intervention eliminates persistent high-risk human papillomavirus (hrHPV) infection. The initial establishment and subsequent progression of cervical cancer mainly depends on two major oncogenes, E6/E7, and previous studies have proposed… read more here.
Keywords: clearance; infection; human papillomavirus; inhibits oncogenes ... See more keywords